欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
AT7519 trifluoroacetate_1431697-85-6_产品详情
1431697-85-6
  • AT7519 trifluoroacetate

  • names:

    AT7519 trifluoroacetate

  • CAS号:

    1431697-85-6

    MDL Number:
  • MF(分子式): C18H18Cl2F3N5O4 MW(分子量): 496.27
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
AT7519 trifluoroacetate
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002300-10mg 10mg 98.16% ¥ 1822.50 ¥ 1822.50 2-3天
- +
¥ 0.00
YZM002300-5mg 5mg 98.16% ¥ 1053.00 ¥ 1053.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1431697-85-6
Inchi
InchiKey
分子式 Formula C18H18Cl2F3N5O4
分子量 Molecular Weight 496.27
溶解度Solubility
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
AT7519 trifluoroacetate(CAS:1431697-85-6)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 AT7519 trifluoroacetate 是一种有效的CDK抑制剂,对 CDK1,CDK2,CDK4-CDK6 以及 CDK9 的IC50值分别为 210,47,100,13,170 和 <10 nM
IntroductionAT7519 trifluoroacetate as a potent inhibitor of CDKs, withIC50s of 210, 47, 100, 13, 170, and <10 nM for CDK1, CDK2, CDK4 to CDK6, and CDK9, respectively.
Application1
Application2
Application3
AT7519 trifluoroacetate 是一种有效的CDK抑制剂,对 CDK1,CDK2,CDK4-CDK6 以及 CDK9 的IC50值分别为 210,47,100,13,170 和 <10 nM。AT7519 trifluoroacetate as a potent inhibitor ofCDKs, withIC50s of 210, 47, 100, 13, 170, and <10 nM for CDK1, CDK2, CDK4 to CDK6, and CDK9, respectively.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Santo L, et al. AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition. Oncogene. 2010 Apr 22;29(16):2325-36.
【2】.Squires MS, et al. Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines. Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines.
【3】.Squires MS, et al. AT7519, a cyclin-dependent kinase inhibitor, exerts its effects by transcriptional inhibition in leukemia cell lines and patient samples. Mol Cancer Ther. 2010 Apr;9(4):920-8.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents